Sovereignty: the best medicine against COVID-19
Compulsory licenses to guarantee access to medical technologies
Fundación GEP filed patent opposition on Hepatitis C treatment
Hepatitis C: In Argentina INPI rejected a key patent on Sofosbuvir
The power of communities against monopolies
Gilead forced to withdraw Truvada® patent application in Argentina